Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Sirakov, M.
Akusherstvo i Ginekologiia 51(1): 63-64
2012
ISSN/ISBN: 0324-0959 PMID: 22639784 Document Number: 659154
Document emailed within 1 workday
Related Documents
Lehtinen, M.; Paavonen, J.; Wheeler, C.M.; Jaisamrarn, U.; Garland, S.M.; Castellsagué, X.; Skinner, S.R.; Apter, D.; Naud, P.; Salmerón, J.; Chow, S.-N.; Kitchener, H.; Teixeira, J.úl.C.; Hedrick, J.; Limson, G.; Szarewski, A.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; De Carvalho, N.S.; Germar, M.J.V.; Peters, K.; Mindel, A.; De Sutter, P.; Bosch, F.X.; David, M.-P.; Descamps, D.; Struyf, F.; Dubin, G.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N 2012: Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 89-99Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
Villa, L.L.; Costa, R.L.R.; Petta, C.A.; Andrade, R.P.; Ault, K.A.; Giuliano, A.R.; Wheeler, C.M.; Koutsky, L.A.; Malm, C.; Lehtinen, M.; Skjeldestad, F.Egil.; Olsson, S-Eric.; Steinwall, M.; Brown, D.R.; Kurman, R.J.; Ronnett, B.M.; Stoler, M.H.; Ferenczy, A.; Harper, D.M.; Tamms, G.M.; Yu, J.; Lupinacci, L.; Railkar, R.; Taddeo, F.J.; Jansen, K.U.; Esser, M.T.; Sings, H.L.; Saah, A.J.; Barr, E. 2005: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet. Oncology 6(5): 271-278
Chirenje, Z.M.; Rusakaniko, S.; Akino, V.; Mlingo, M. 2001: A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 21(6): 617-621
Denny, L.; Hendricks, B.; Gordon, C.; Thomas, F.; Hezareh, M.; Dobbelaere, K.; Durand, C.; Hervé, C.; Descamps, D. 2013: Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study Vaccine 31(48): 5745-5753
Kerac, M.; Bunn, J.; Seal, A.; Thindwa, M.; Tomkins, A.; Sadler, K.; Bahwere, P.; Collins, S. 2009: Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi Lancet 374(9684): 136-144
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Narayanan, P.R. 2006: Influence of sex, age and nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India Indian Journal of Medical Research 123(2): 119-124
Kakkar, V.V.; Corrigan, T.; Spindler, J.; Fossard, D.P.; Flute, P.T.; Crellin, R.Q.; Wessler, S.; Yin, E.T. 1972: Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial Lancet 2(7768): 101-106
Bobat, R.; Coovadia, H.; Stephen, C.; Naidoo, K.L.; McKerrow, N.; Black, R.E.; Moss, W.J. 2005: Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial Lancet 366(9500): 1862-1867
Vellas, B.; Andrieu, S.; Ousset, P.J.; Ouzid, M.; Mathiex-Fortunet, H. 2006: The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint Neurology 67(9 Suppl 3): S6-S11
Pai, K.; Pai, S.; Gupta, A.; Rao, P.; Renjhen, P. 2006: Synchronous vulvar intraepithelial neoplasia (VIN) of warty type and cervical intraepithelial neoplasia (CIN): case report Indian Journal of Pathology and Microbiology 49(4): 585-587
Abdulla, S.; Eckhardt, R.; Netter, U.; Abdulla, W. 2012: Efficacy of three IV non-opioid-analgesics on opioid consumption for postoperative pain relief after total thyroidectomy: a randomised, double-blind trial Middle East Journal of Anaesthesiology 21(4): 543-552
Erwin, E.; Aronson, K.J.; Day, A.; Ginsburg, O.; Macheku, G.; Feksi, A.; Oneko, O.; Sleeth, J.; Magoma, B.; West, N.; Marandu, P.Dominic.; Yeates, K. 2019: SMS behaviour change communication and eVoucher interventions to increase uptake of cervical cancer screening in the Kilimanjaro and Arusha regions of Tanzania: a randomised, double-blind, controlled trial of effectiveness Bmj Innovations 5(1): 28-34
Coovadia, H.M.; Brown, E.R.; Fowler, M.Glenn.; Chipato, T.; Moodley, D.; Manji, K.; Musoke, P.; Stranix-Chibanda, L.; Chetty, V.; Fawzi, W.; Nakabiito, C.; Msweli, L.; Kisenge, R.; Guay, L.; Mwatha, A.; Lynn, D.J.; Eshleman, S.H.; Richardson, P.; George, K.; Andrew, P.; Mofenson, L.M.; Zwerski, S.; Maldonado, Y. 2012: Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial Lancet 379(9812): 221-228
Bose, K. 1999: The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial Methods and Findings in Experimental and Clinical Pharmacology 21(3): 209-213
Lee, H.Y. 1997: A randomised double-blind study of vaginal misoprostol vs dinoprostone for cervical ripening and labour induction in prolonged pregnancy Singapore Medical Journal 38(7): 292-294
Lundhus, E.; Gottrup, F. 1993: Outcome at three to five years of primary closure of perianal and pilonidal abscess. A randomised, double-blind clinical trial with a complete three-year followup of one compared with four days' treatment with ampicillin and metronidazole European Journal of Surgery 159(10): 555-558
Placidi, G.F.; Lenzi, A.; Lazzerini, F.; Cassano, G.B.; Akiskal, H.S. 1986: The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients Journal of Clinical Psychiatry 47(10): 490-494
Reichelt, A.; Förster, K.K.; Fischer, M.; Rovati, L.C.; Setnikar, I. 1994: Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. a randomised, placebo-controlled, double-blind study Arzneimittel-Forschung 44(1): 75-80